Outrage could lead to lowering price of high-cost drugs

San Francisco Chronicle
By Victoria Colliver | September 22, 2015

Outrage over a pharmaceutical company’s decision to increase the price of a decade sold drug by 5,000 percent ignited debate for measures to impose anti-gouging regulations in an industry that’s free to charge whatever it wants for its products.

Keith Yoshizuka, assistant dean of administration for the College of Pharmacy at Vallejo’s Touro University ... said federal laws prevent drug manufacturers from price fixing or colluding on prices, but prices aren’t regulated.

Continue reading on the San Francisco Chronicle website